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Abstract: A novel porous composite material composed
of hydroxyapatite, poly(vinyl alcohol) (PVA), and gelatin
(Gel) was fabricated by emulsiﬁcation. Scanning electron
microscopy showed that the material had a well-inter-
connected porous structure including many macropores
(100–500 lm) and micropores (less than 20 lm) on their
walls. The composite had a porosity of 78% and showed
high water absorption up to 312.7% indicating a good
water-swellable behavior that is a characteristic of hydro-
gel materials. When immersed in water, the scaffold’s
weight continuously decreased. After immersion in simu-
lated body ﬂuid, the weight continuously increased
because Ca2þ and PO4
3 ions deposited on the surface
and the internal surfaces of the material pores. The de-
posit was proved to be carbonated hydroxyapatite by
thin-ﬁlm X-ray diffraction, Fourier transform infrared
spectroscopy and energy dispersive X-ray analysis. The
composite was detected to be non-cytotoxicity by MTT
assay. The HA/PVA/Gel material was also implanted
subcutaneously in the dorsal region of adult female rats.
After 12 weeks of implantation, the porous material
adhered tightly with the surrounding tissue, and the
ingrowth of ﬁbrous tissue as well as the material’s partial
degradation was observed, which partly indicated that
the composite was biocompatible in vivo. In conclusion,
the porous HA/PVA/Gel composite is a promising scaf-
fold for cartilage tissue engineering with more studies.
 2007 Wiley Periodicals, Inc. J Biomed Mater Res 85A:
418–426, 2008
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INTRODUCTION
During physical movement, articular cartilage
plays a major role in lubrication as well as reduction
of vibration in the joints. As cartilage has a limited
potential for self-repair, treatment of cartilage lesions
is one of the most challenging problems in orthope-
dic surgery. Transplantation of isolated chondrocytes
has long been acknowledged as a potential method
for regenerating the cartilage defects that is damaged
or deformed.1 However, recent advance in tissue en-
gineering allow us to aim on the production of
larger amounts of cartilaginous tissue, which subse-
quently can be used for the reconstruction of carti-
lage lesions.2,3 Tissue engineering is based on the
utilization of morphogens, scaffold, and stem cells.
The design of an appropriate scaffold material is one
of the major issues. For the engineering of cartilage,
the scaffold material must meet speciﬁc require-
ments, like: (1) allowing bone binding at the bony
side of the chondral defect; (2) being water-swellable
to facilitate lubrication and vibration reduction; (3)
permitting the ingrowth of cartilage (nontoxic, bio-
compatible, and porous); and (4) showing degrada-
tion during time, while being replaced with carti-
lage. Hydrogel, a hydrophilic but water-insoluble
polymeric material that is composed of natural or
synthetic polymers, appear to be the ideal candidate
as scaffold material for cartilage tissue engineering.
This is due to the fact that the material is very simi-
lar to natural cartilage in terms of its mechanical and
structural properties. A hydrogel that has already
been used for biomedical applications is poly(vinyl
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alcohol) (PVA). This material has been selected due
to its good biocompatibility and desirable physical
properties such as elasticity and water-swelling
behavior. Furthermore, hydroxyapatite (HA) has
been proven to be bone biocompatible and osteocon-
ductive, and has shown the ability to induce calciﬁ-
cation and form a biological bond between implant
and subchondral bone.4,5 Finally, gelatin (Gel) has
similar peptide chains as compared with the colla-
gen ﬁbers in cartilage, which may facilitate cellular
adhesion and proliferation. The incorporation of Gel
can also improve the degradation of a biomaterial.6
In view of the earlier mentioned, in the current
study a porous HA/PVA/Gel composite was fabri-
cated and evaluated in vitro and in vivo to determine
its biocompatibility and biodegradable behavior for
its feasibility of cartilage tissue engineering scaffold.
MATERIALS AND METHODS
Materials
HA slurry prepared by wet method7 was ultrasounded
to diffuse uniformly in deionized water before mixing.
PVA (mean degree of polymerization: 1700 6 50) and Gel
(AR) were purchased from BeiPei Chemical Agent Factory
of Chongqing, China and Tianjin Kermel Chemical
Reagents Development Center, China, respectively. Simu-
lated body ﬂuid (SBF) was prepared by dissolving appro-
priate quantities of the reagents in sterilized water. The
reagents were added one by one after each reagent was
completely dissolved in 1000 mL water according to the
order as listed in Table I. This solution was then adjusted
with 1 mol/L HCl and NH2C (CH2OH) 3 to a pH of 7.4 at
378C.
Fabrication of HA/PVA/Gel composite
HA, PVA, and Gel were added into a three-neck bottle
with water, and the weight ratio was 3:6:1. The solution
was stirred at 608C for 2 h and then at 958C for another 2
h. After the mixture of HA, PVA, and Gel was prepared,
emulsiﬁer (Tween 20) was added into a beaker with con-
tinuous stirring for 15 min at 800 rpm in order to get a
foam mixture with gas bubbles. The foam mixture was
then poured into a Petri dish that was exposed to ﬁve
repeated cycles of freezing at 228C and thawing at 208C.
The prepared samples were immersed in water for two
weeks that was refreshed every day to dissolve Tween 20.
Dried scaffolds were obtained after freeze-drying for 36 h.
Microstructure of the scaffold
After sputter coating with gold, the cross-section of
dried scaffolds was examined with scanning electron mi-
croscopy (SEM) (JSM-5900LV). To evaluate the distribution
of HA, ﬁve micro-areas (10 nm 3 10 nm) were randomly
selected on the cross-section and the relative contents of
Ca and P (atom number) in these micro-areas were
detected with energy dispersive X-ray analysis (EDAX,
Philip 9100-60). Pore size of the scaffold was measured
and the porosity was calculated by the weight and volume
of the scaffold before and after immersion in water.
Swelling test
Twelve dried samples with a porosity of 78 and 56%
were placed at 378C into culture plates ﬁlled with sterile
water and SBF, respectively. When swelling equilibrium
was reached at 36 h, the samples were taken out and the
water on the surfaces was blotted with ﬁlter papers. The
samples were weighed before and after immersion. Water
absorption of the scaffolds in distilled water and in SBF
was calculated by a gravimetric procedure.
Immersion test
To investigate the bioactivity and degradation behavior
of HA/PVA/Gel scaffolds, immersion tests were per-
formed in SBF and distilled water. According to the differ-
ent immersion ﬂuid and composites’ porosity, immersion
test was divided into four groups (high porosity in water,
low porosity in water, high porosity in SBF, and low po-
rosity in SBF) and each group had three samples. The sam-
ples were immersed in tubes ﬁlled with 50 mL SBF or dis-
tilled water and placed in a reciprocal shaking incubator
shaker at 378C. Each week, samples were taken out of the
soak ﬂuids. Subsequently, these samples were washed
with deionized water and dried to constant weight at
608C. Also, the SBF solution was refreshed every week to
maintain the ion concentration that decreased due to depo-
sition of calcium and phosphorus on the specimens. The
per-week weight loss of the scaffolds was calculated and
plotted until 8 week. The surfaces of the dried scaffolds
that had been immersed for 4 and 8 weeks were examined
with SEM (JSM-5900LV). After 8 weeks immersion, the de-
posit on the surface of the samples was characterized with
thin-ﬁlm X-ray diffraction, Fourier transform infrared spec-
troscopy (FTIR) and EDAX (Philip 9100-60), respectively.
TABLE I
Chemical Composition of SBF
Order Reagent Weight (g)
1 NaCl 7.996
2 NaHCO3 0.3500
3 KCl 0.2440
4 K2HPO43H2O 0.2280
5 MgCl2H2O 0.3050
6 1 mol/L HCl 40 mL (volume)
7 CaCl2 0.2780
8 Na2SO4 0.0710
9 NH2C (CH2OH)3 6.057
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Evaluation of cytotoxicity
A 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium
bromide (MTT) assay was used to evaluate the cytotoxicity
of the HA/PVA/Gel composite. Because the reduction of
the tetrazolium salt into a blue color product (formazan)
only occurs in metabolically active cells, the amount of form-
azan produced is proportional to the number of living cells.8
By measuring the optical density (OD) value of the forma-
zan, the percentage of viable cells can be determined.
Rabbit ﬁbroblast provided by the Cell Bank of Peking
Union Medical College was used as test cells. MTT agent
was prepared by dissolving 5 mg MTT in 1 mL phosphate
buffered solution (PBS). The procedure of MTT assay was
as follows: (i) Preparation of extraction ﬂuids of the com-
posite: The composite was cut into small pieces (4 mm 3 4
mm 3 1 mm), which were sterilized by Gamma-ray radia-
tion. The pieces were added to culture ﬂasks, which con-
tained the culture ﬂuid, that is, nutrition medium F12
(GIBCO USA), 10% fetal bovine serum (GIBCO USA), and
penicillin–streptomycin solution (100 units of penicillin
and 100 lg of streptomycin per milliliter). The culture
ﬂasks were placed in an incubator at 378C and 5% CO2 for
24 h. (ii) Preparation of the cell suspension: Rabbit ﬁbro-
blasts were grown and passaged in the culture ﬂuid. Third
generation ﬁbroblasts were detached with 0.25% paren-
zyme (GIBCO USA) and suspended in cell culture medium
at a 5 3 103 cells/mL. Subsequently, 0.2 mL cell suspen-
sion was added to each well of three 96-well culture plates
that were put in the incubator. Each culture plate was di-
vided into an experimental part, which consisted of 10
wells and a control part which including 5 wells. (iii)
Replacement of initial cell culture medium: After 24 h of
cell culture, for each well of 5 wells in experimental part,
the initial cell culture medium was replaced with 0.2 mL
extraction ﬂuid, and other 5 wells in experimental part
was replaced with 0.1 mL extraction ﬂuid and 0.1 mL
earlier-mentioned culture ﬂuid. Each well in the control
group was added with 0.2 mL the culture ﬂuid. Finally,
the wells plate was put back into the incubator. (iv) Detec-
tion of OD value: After 24, 48, and 72 h of incubation, 0.02
mL MTT agent were added to each well. After 4 h of incu-
bation, 0.15 mL dimethyl sulphoxide (DMSO) was added
to each well and the culture plate was slightly shaked for
10 min. The OD value of each well was assessed with an
enzyme-connection immunodetection apparatus (BIO-RAD
Model 550).
Cell shape
Rabbit ﬁbroblasts were grown in the culture medium
composed of the nutrition medium F12, 10% fetal bovine
serum and penicillin-streptomycin solution (100 units of
penicillin and 100 lg of streptomycin per milliliter). Third
generation ﬁbroblast were suspended at a concentration of
9.5 3 104 cells/mL after detachment with 0.25% paren-
zyme and 0.2% ethylenediamine tartrate acid (EDTA).
Composite material was cut into pieces (18 mm 3 18 mm
3 1 mm) and sterilized by Gamma-ray radiation. The
square-shaped composite discs were placed at the bottom of
each well of a 12 wells plate and 1 mL of cell suspension
was added to each well. In one well of each 12 well plate,
no composite material was placed. This well was used as
control surface. Subsequently, the 12-well plates were incu-
bated at 378C and 5% CO2. After 24 h of incubation, the
supernatant liquid was removed and each well was supple-
mented with 1 mL culture ﬂuid and 0.005 mL adenovirus-
epidermal growth factor receptor (AD-EGFR) that was used
as ﬂuorescin agents. Subsequently, the plates were put back
into the incubator for another 72 h. Then, the shape of the
ﬁbroblasts in the experimental group and control group was
examined with an inverted microscope (Olympus) under the
background of ﬂuorescence.
In vivo evaluation
The biocompatibility and biodegradation of the compos-
ite material was evaluated by subcutaneous implantation
in the dorsal region of adult female rats. All animal studies
were performed according to the related laws (Animal
Care and Use Committee, No: 23.0835.1.0; OECD Princi-
ples of Good Laboratory Practice).
Six four-month-old female rats (about 300 g) were anes-
thetized, and two subcutaneous pockets were made on the
right and left dorsal region of each rat. Gamma-ray-steri-
lized composite disks (4 mm 3 4 mm 3 1.5 mm) were
inserted into the pockets (always in the same position).
After implantation time of 1, 4, and 12 weeks, the animals
were sacriﬁced and the implants were harvested with sur-
rounding tissue. The explants were immediately ﬁxed by
immersion in 2.5% glutaraldehyde solution and kept at
48C for 24 h. After dehydration in a graded series of alco-
hol, the specimens were embedded in parafﬁn. Light
microscopical sections were made, which were stained
with hematoxylin and eosin (H&E). Thereafter, microscopi-
cal evaluation was done (Nikon TE2000-U).
RESULTS AND DISCUSSION
Microstructure of the scaffolds
SEM micrographs of the cross-section of HA/
PVA/Gel scaffold (Fig. 1) revealed two distinct pore
sizes: (i) macropores of 100–500 lm, and (ii) micro-
pores of less than 20 lm, which were located on the
walls of the macropores. All pores formed a well-
interconnected network. It is obvious that the porous
structure is beneﬁcial for tissue ingrowth and ﬂow
transport of nutrients and metabolic waste. From the
micrographs, the evident aggregates of HA cannot
be observed. In Figure 2, the approximate contents
of Ca and p value in ﬁve micro-areas of the cross-
section of the scaffold indicate that the HA particles
are uniformly distributed in the polymer matrix. It is
important for the ﬁnal mechanical and biological
performance that inorganic particles uniformly dis-
tribute in particle-reinforced composites.9
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By measuring the weight and volume of the com-
posites before and after soaking in water, the poros-
ity (P) of the composite was calculated via the fol-
lowing equation [Eq. (1)]:
P ¼ 1Md 3 Vs
Ms 3 Vd
 
3 100% ð1Þ
where Md and Vd are the weight and volume of
dried scaffold, and Ms, Vs are the weight and vol-
ume of swollen scaffold. Using this formula, the
porosity of the scaffold, as shown in Figure 1, was
between 50 and 80%. By changing the parameters,
scaffolds with different porosities can be fabricated
according to speciﬁc requirements.10
Swelling test
A gravimetric procedure11 was carried out to mon-
itor the water absorption of two dried HA/PVA/Gel
composites with porosity of 78 and 56%. Water
absorption (A) was calculated via the following
equation [Eq. (2)]:
A ¼ Ws Wd
Wd
3 100% ð2Þ
where Ws and Wd are the weight of swollen and
dried gel. The results (Table II) show that the HA/
PVA/Gel composite with 78% porosity has water
absorption of about 300% due to excellent hydro-
philic nature of PVA and Gel. The maximum water
absorption is 312.7% in water and 294.3% in SBF.
Highly porous scaffolds possess a high water
absorption, which is attributed to the presence of an
increased space to hold endosmic water as well as
an increased contact area to react with water. This
indicates that the water content can be partly con-
trolled by changing the composite porosity. Hydro-
gel is used for the manufacture of the replacement
of soft tissue, such as cartilage, intraocular tissue,
and so forth, just because of its excellent property of
being water-swellable and the consequent lubricative
nature, which plays a key role in the function of
vibration reduction.12
The data as listed in Table II also show that the
water absorption in water is higher than in SBF,
which is explained by the fact that with the addition
of the ions in SBF, the osmotic pressure of water
decreases between the exterior and interior of the
swelling gels. This phenomenon has been reported
before by other researchers.13
Figure 1. SEM micrographs of HA/PVA/Gel composite: (A) a cross-section of the scaffold, (B) micropores on the walls
of the macropores.
Figure 2. The distribution of the relative contents of Ca
and P in the composite. [Color ﬁgure can be viewed in the
online issue, which is available at www.interscience.wiley.
com.]
TABLE II
Water Absorption of HA/PVA/Gel Composites
in Water and SBF
Immersion Fluid Water (%) SBF (%)
Porosity (%) 78 56 78 56
Group 1 304.4 291.2 294.3 276.2
Group 2 305.3 284.6 278.5 265.3
Group 3 312.7 296.3 286.3 260.2
Average 307.5 290.7 286.4 267.2
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Immersion test
Weight loss analysis
High porosity (78%) and low porosity composites
(56%) were immersed in water and SBF solution.
They were weighed before and after immersion and
the weight loss per week was calculated according
to the following equation [Eq. (3)]:
Weight loss ¼ Wi Wd
Wi
3 100% ð3Þ
where Wi and Wd are the initial dried weight and
post-immersion dried weight of the composites.
Figure 3 shows the weight loss of composites
with a different porosity in water and SBF at vari-
ous time intervals. Each point in Figure 3 combines
the average value of three samples and their stand-
ard deviations. It can be seen that: (i) the weight
loss in water continually increases during time for
high porosity and low porosity composites, and
that the high porosity composite shows a relative
high weight loss within the same time interval. The
weight loss is mainly attributed to the degradation
of Gel. (ii) In SBF, the weight loss of high and low
porosity composites continuously decreases from 1
to 8 weeks so that at the end of 8 week the sam-
ple’s weight far surpasses the weight before
immersion. This is attributed to the degradation of
the composites as well as the deposition of Ca2þ
and PO4
3 ions out of SBF on the composite and
pore surface. The weight loss decreases when the
deposition dominates. (iii) In SBF, because of a bet-
ter permeability of the ions and the higher surface
area of the composites, the deposition of Ca2þ and
PO4
3 ions is faster in high porosity composites
than in the low ones. Therefore, the decrease of
weight loss of the high porosity composites is also
faster.
Hydrolysis of peptide bonds and cross-links is the
main mechanism of Gel degradation in a non-enzy-
matic solution.14,15 Thus, degradation of the scaffold
is attributed to the hydrolysis of Gel. In this test, the
hydrolysis of the composites can be promoted by
persistent shaking at 378C simulating the in vivo con-
ditions. The presence of cross-linking via chemical
bonds in HA/PVA/Gel composite has been veriﬁed
in another publication.6 The prolonged degradation
time conﬁrms that HA/PVA/Gel composite has a
good degree of cross-linking, because pure Gel com-
pletely takes a degradation within a conspicuous
short time.16,17
Characterization of the mineral deposit
SEM micrographs of the scaffolds immersed in
SBF for 4 and 8 weeks are presented in Figure 4.
They show that some minerals deposited on the
pore walls of the composites after 4 weeks of immer-
Figure 3. Weight loss of HA/PVA/Gel composites after
immersion. (~) High porosity in water, () low porosity
in water, (&) high porosity in SBF, (3) low porosity in
SBF.
Figure 4. SEM micrographs of cross-sections of HA/PVA/Gel composite after 4 weeks (A) and 8 weeks (B) of immersion
in SBF.
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sion [Fig. 4(A)]. After 8 weeks of immersion
[Fig. 4(B)], a lot of minerals covered the surface and
the internal walls of the pores. The thin-ﬁlm X-ray
diffraction of the mineralized deposit is depicted
in Figure 5. The characteristic peaks of HA locating
at 25.98, 31.88, 40.08, 46.78, 49.58 appear clearly in
the spectrum of the deposit. The FTIR pattern of
the mineralized deposit (Fig. 6) presents the charac-
teristic peaks of PO4
3 at 1032 and 1087 cm1 and
the peak at 1320 cm1 corresponding to hydroxyl
bending vibration. Moreover, the peak at 1423 cm1
indicates the presence of CO3
2 in the deposit.
EDAX analysis conﬁrms that Ca/P ratio value of
the deposit is 1.75 that is beyond 1.67 of HA due to
the presence of CO3
2. These results manifest that
the deposit is a carbonated HA that is similar
in composition to bone apatite. The deposition
phenomenon proves that the composite is a bioac-
tive material, which can induce a biological bond
with bone.18
Evaluation of cytotoxicity
An MTT assay with rabbit ﬁbroblast was done to
evaluate the cytotoxicity of the composites. The rela-
tive growth rate (RGR) of the ﬁbroblast in the extrac-
tion ﬂuid of HA/PVA/Gel composite was assessed.
RGR was calculated via the following equation [Eq.
(4)]:
RGR ¼ ODe
ODc
3 100% ð4Þ
where ODe and ODc are the average OD value of
the experimental and control groups. The results
(Table III) show that RGR decreases with culture
time and increases with a decreasing concentration
of extraction ﬂuids, which corroborates with other
studies.19,20 The data also demonstrate that the
ﬁbroblasts have a high RGR in the composite
extraction ﬂuid, which proves a good cell-viability.
The toxicity grade (CTG) of the composite is
obtained by the relationship between RGR and CTG
according to standard GB/T 16886-1997 (Table
IV).21 CTG of the composite is grade 1 at 24 and 48
h, indicating non-toxicity. At 72 h, the CTG of the
composite increases to grade 2, but it is concluded
that the composite is non-toxicity by referring to
the intensive viability of the ﬁbroblasts at 72 h of
cell culture in Figure 7.
Cell shape
Figure 7 show that the ﬁbroblasts are a long fusi-
form shape with copious endochylema and an ellip-
tical nucleus. The ﬁbroblasts proliferate on the exper-
imental composite surfaces and some cells revealed
cleavage, which was conﬁrmed by the observation of
separating nuclei. The viability of the cells was on a
high level, as indicated by the presence of a great
number of living cells. This proves that the HA/
PVA/Gel composite is cell compatible.
Figure 5. Thin-ﬁlm X-ray diffraction pattern of the miner-
alized deposit.
Figure 6. FTIR spectrum of the mineralized deposit.
TABLE III
RGR and CTG of Rabbit Fibroblasts Grown in the
Extraction Fluid of HA/PVA/Gel Composite
Concentration of
Extraction
Fluid (%)
RGR (%) CTG
24 h 48 h 72 h 24 h 48 h 72 h
100 83.6 75.4 54.0 1 1 2
50 83.7 81.0 55.6 1 1 2
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In vivo evaluation
Evaluation of the retrieved composite implants
was done by macroscopic observation and light mi-
croscopy. After 1 week of implantation, the implants
were located in a subcutaneous pocket that was
clearly separated from the surrounding tissue. At 4
weeks, ﬁbrous tissue formation started resulting in
encapsulation of the implant. At 12 weeks, the
implants adhered tightly to the surrounding tissue,
and the district of the implantation resembled the
surrounding original tissue.
Light micrographs of histological sections after 1,
4, and 12 week(s) of implantation are depicted in
Figure 8. At 1 week [Fig. 8(A,B)], a lot of inﬂamma-
tory cells were seen within and around the implant.
Evidently, a phagocytotic and inﬂammatory reaction
occurred. After 4 weeks of implantation [Fig.
8(C,D)], the number of inﬂammatory cells decreased
sharply, but the ﬁbrous capsule was still present. Fi-
brous tissue was growing into the implant pores. At
12 weeks, the implant was completely penetrated
with ﬁbrous tissue. Further, it was noticed that the
surrounding ﬁbrous capsule became much thinner
[Fig. 8(E)]. The implant had partially degraded,
which could be associated with a very mild inﬂam-
matory response [Fig. 8(F)]. As a lot of enzymes are
present in vivo, the partial degradation of the HA/
PVA/Gel composite is mainly attributed to enzymol-
ysis of Gel.16,22
CONCLUSION
A novel HA/PVA/Gel composite was prepared
by an emulsiﬁcation approach. The porous micro-
structure of the HA/PVA/Gel composite was found
to be well-interconnected via a lot of micropores on
the walls of macropores. The pores with a size of
100–500 lm in diameter allowed the ingrowth of tis-
sue. The porous composite shows excellent water-
swelling behavior and high water absorption up to
294.3% in SBF. After 8 weeks of immersion, the
weight loss of the composite increased in water and
decreased in SBF. At the end of 8-week immersion, a
lot of apatite crystals that had proved to be carbo-
nated HA were formed on the surface and internal
walls of the pores. The composite was also con-
ﬁrmed to be nontoxic and cell-compatible by MTT
assay and cell culturing.
In subcutaneous implantation in rats, an inﬂam-
matory reaction was seen during the initial stage of
implantation. After 12 weeks of implantation, ﬁbrous
tissue had grown into the porous composite
implants. The occurrence of local defects in the com-
posite indicates that the material is biodegradable.
On the basis of earlier mentioned text, we con-
clude that the in vitro and in vivo results show that
the HA/PVA/Gel composite posses good character-
istics so that it can be further researched as a scaf-
fold material for cartilage tissue engineering.
TABLE IV
Relations Between CTG, RGR, and Toxicity
(China standard, GB/T 16886.5-1997)
CTG RGR (%) Toxicity
0 100 No
1 75–99
2 50–74 Slightly*
3 25–49 Midrange
4 1–24
5 0 Obvious
*Evaluated by referring to the viability of cell cultured.
Figure 7. Micrographs of the ﬁbroblasts under back-
ground of ﬂuorescence after 72 h of culture. Experimental
group (A) was cultured on the HA/PVA/Gel composite
and the control group (B) was the bottom of a well dish.
[Color ﬁgure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
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Figure 8. Light micrographs of HA/PVA/Gel composite, which was subcutaneously implanted in the dorsal region of
adult female rats for 1 (A, B), 4 (C, D), and 12 weeks (E, F). The regions as indicated by black squares in (A, C, and E)
were magniﬁed to (B, D, and F). Black arrows in (B, D, and F) show ingrowth of tissue and white arrows in (B, D, and F)
show the presence of inﬂammatory cells. All sections were stained with H&E. [Color ﬁgure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
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